Stock News

Arcutis Biotherapeutics Announces FDA Acceptance of sNDA for ZORYVE Foam Introduction The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of May 22, 2025 for Arcutis Biotherapeutics’ supplemental New Drug Application (sNDA) for ZORYVE (roflumilast) foam 0.3%. This next-generation phosphodiesterase-4 (PDE4) inhibitor is aimed at…

Spectral AI, Inc. Achieves Significant Milestone in Burn Pivotal Study Introduction In a recent press release, Spectral AI, Inc. announced that it has reached a major milestone in its U.S. Burn Pivotal Study. The company, known for its focus on leveraging artificial intelligence for medical diagnostics in wound care, has successfully enrolled 25% of the…

New Data on Opioid Use Disorder Program at Society for Neuroscience Meeting Ensysce CEO Invited Expert Speaker at Formulation & Delivery US 2024 Meeting SAN DIEGO, CA / ACCESSWIRE / September 24, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (“Ensysce” or the “Company”), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing…

PayPoint plc Share Incentive Plan Transactions Notifications of transactions by PDMRs 23 September 2024 PayPoint plc has released details regarding the monthly acquisition of Partnership Shares and award of Matching Shares under the PayPoint plc Share Incentive Plan (SIP) on 23 September 2024. This includes transactions made by Persons Discharging Managerial Responsibilities (PDMRs), which includes…

Remains Committed to Supporting the Best Outcome for All Vista Shareholders Encouraging an All-Cash Transaction for Vista Outdoor Gates Capital Management, Inc. (“Gates Capital Management” or “we”), an event-driven alternative asset manager that beneficially owns 5,589,041 shares of common stock, or approximately 9.6%, of Vista Outdoor, Inc. (“Vista” or the “Company”) (NYSE: VSTO), has issued…

News Release Highlights: Extended Research Partnership with Global Top 20 Ranked University Battery X Metals Collaboration with Top University for Eco-Friendly Technology Development Battery X Metals has recently announced an amendment and extension of its research collaboration with a global Top 20 ranked university. The partnership aims to further advance the development of Battery X…

Thunder Gold Corp Announces Work Program at Tower Mountain Gold Property Overview Thunder Gold Corp (TSXV: TGOL) has deployed field teams to its 2,500 hectare Tower Mountain Gold Property located in the Shebandowan Greenstone Belt, west of Thunder Bay, Ontario. The work program includes soil geochemical surveys, reconnaissance mapping and sampling, clearing and surface sampling,…

Cardiol Therapeutics Successfully Enrolls Target Number of Patients in Phase II ARCHER Trial for CardiolRxTM Treatment of Acute Myocarditis Description Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic…